Equities

Envista Holdings Corp

Envista Holdings Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)22.18
  • Today's Change0.70 / 3.26%
  • Shares traded2.31m
  • 1 Year change-7.97%
  • Beta1.3123
Data delayed at least 15 minutes, as of Nov 25 2024 23:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy2
Outperform1
Hold10
Sell0
Strong Sell0

Share price forecast in USD

The 11 analysts offering 12 month price targets for Envista Holdings Corp have a median target of 21.00, with a high estimate of 26.00 and a low estimate of 17.00. The median estimate represents a -5.32% decrease from the last price of 22.18.
High17.2%26.00
Med-5.3%21.00
Low-23.4%17.00

Earnings history & estimates in USD

On Oct 30, 2024, Envista Holdings Corp reported 3rd quarter 2024 earnings of 0.12 per share. This result exceeded the 0.09 consensus of the 12 analysts covering the company and under-performed last year's 3rd quarter results by 72.09%.
The next earnings announcement is expected on Feb 05, 2025.
Average growth rate-22.88%
Envista Holdings Corp reported annual 2023 earnings of 1.53 per share on Feb 07, 2024.
Average growth rate+6.81%
More ▼

Revenue history & estimates in USD

Envista Holdings Corporation had 3rd quarter 2024 revenues of 601.00m. This bettered the 590.30m consensus of the 12 analysts covering the company. This was 4.18% below the prior year's 3rd quarter results.
Average growth rate-1.17%
Envista Holdings Corporation had revenues for the full year 2023 of 2.57bn. This was 0.10% below the prior year's results.
Average growth rate-1.21%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.